4
Changes in Ownership
Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-22-036236
Options or other derivatives
- President and CEO acquired 1,988,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jabbour Jerome D President and CEO | 2022-12-20 | Grant or award · Stock Option (right to Buy) | +1,988,300 | 1,988,300 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…